Marketplace / Healthtech / Pre-Seed
HarmonIQ Biosciences
“Empowering health through continuous hormone monitoring.”
Open round — HarmonIQ Biosciences is raising $2.0M for its Pre-Seed
The founder is taking investor conversations now, and on PitchSpark you reach them directly — no warm intro, no gatekeeper. Create a free investor account to see the financials and the deck, then message the founder in one click.

Overview
Founded by Mario Sierra, CCRC, HarmonIQ Biosciences aims to redefine personal health understanding by making continuous hormone insights accessible to everyone. Their mission is to empower individuals to take control of their health through real-time, science-driven data.
Traction
as reported by the founderHarmonIQ Biosciences completed a seed funding round on May 2, 2025, indicating strong investor confidence in their innovative approach.
The company addresses the lack of accessible, real-time hormone data, enabling individuals to monitor hormonal changes continuously and make informed health decisions.
HarmonIQ's competitive advantage lies in its unique aptamer-based sensing platform integrated into wearable technology, offering precise and continuous hormone monitoring previously confined to laboratory settings.
The wearable health technology market is rapidly expanding, with increasing consumer demand for personalized health monitoring solutions.
Main competitors include BioSens8 and Personalized Lifestyle Medicine Institute. HarmonIQ differentiates itself through its innovative wearable device and real-time hormone data delivery.
Company updates
No updates posted yet.
Follow this company
Get an email when HarmonIQ Biosciences posts an update. No account needed — one click to unsubscribe.
HarmonIQ Biosciences — raising $2.0M
Deck · financials · founder contact